-
Life-threatening conditions in children include purpura fulminans and other severe infections (endocarditis, ecthyma gangrenosum), scarla-tiniform skin rash evoking a toxic shock and acute loss of skin or mucous membranes (drug reaction or post-infectious).
-
Chickenpox is the most frequent underlying condition of severe cellulitis in children.
-
The presence of a persistent fever of more than 5 days, in association with a polymorphous skin rash, would suggest Kawasaki disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bay A, Oner AF, Calka O, Sanli F, Akdeniz N, Dogan M (2006) Purpura fulminans secondary to transient protein C deficiency as a complication of chickenpox infection. Pediatr Dermatol 23(4):412–423
Perrocheau A, Taha MK, Levy-Bruhl D (2005) Epidemiology of invasive meningococcal disease in France in 2003. Euro Surveill 10(12):238–241
Reinert P (2001) Epidemiology of purpura fulminans and early therapeutic recommendations. Arch Pediatr 8(Suppl 4): 673s–676s
Hussain A, Robinson G, Malkin J, Duthie M, Kearns A, Perera N (2007) Purpura fulminans in a child secondary to Panton– Valentine leukocidin-producing Staphylococcus aureus. J Med Microbiol 56(Pt 10):1407–1409
Boisseau AM, Sarlangue J, Perel Y, Hehunstre JP, Taïeb A, Maleville J (1992) Perineal ecthyma gangrenosum in infancy and early childhood: septicemic and nonsepticemic forms. J Am Acad Dermatol 27(3):415–418
Sarlangue J, Brissaud O, Labrèze C (2006) Clinical features of Pseudomonas aeruginosa infections. Arch Pediatr 13(Suppl 1): S13–S16
Marcinak JF, Frank AL (2006) Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Expert Rev Anti Infect Ther 4(1):91–100
Hedrick J (2003) Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment. Paediatr Drugs 5(Suppl 1):35–46
Brockow K, Jofer C, Behrendt H, Ring J (2008) Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 63(2):226–232
Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R (2007) Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 92(12):1062–1066
Ziebold C, von Kries R, Lang R et al (2001) Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 108:79–84
Peng WM, Jenneck C, Bussmann C, Bogdanow M, Hart J, Leung DY, Bieber T, Eis-Hübinger AM, Novak N (2007) Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 127(5):1261–1263
Dore J, Salisbury RE (2007) Morbidity and mortality of mucocutaneous diseases in the pediatric population at a tertiary care center. J Burn Care Res 28(6):865–870
Léauté-Labrèze C, Lamireau T, Chawki D, Maleville J, Taïeb A (2000) Diagnosis, classification, and management of erythema multiforme and Stevens–Johnson syndrome. Arch Dis Child 83(4):347–352
Spies M, Sanford AP, Aili Low JF, Wolf SE, Herndon DN (2001) Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 108(5):1162–1168
Dajani AS, Taubert KA, Gerber MA et al (1993) Diagnosis and therapy of Kawasaki disease in children. Circulation 87:1776–1780
Oates-Whitehead RM, Baumer JH, Haines L et al (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 4:CD004000
Freeman AF, Shulman ST (2006) Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 74:1141–1148
Baumer JH, Love SJ, Gupta A et al (2006) Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 4:CD004175
Burns JC, Mason WH, Hauger SB et al (2005) Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 146:662–667
Inoue Y, Okada Y, Shinohara M et al (2006) A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 149:291–292
Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14(5):548–552
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Léauté-Labrèze, C., Boralevi, F., Taïeb, A. (2009). Life-Threatening Dermatoses and Emergencies in Dermatology: The Case of the Paediatric Patient. In: Revuz, J., Roujeau, JC., Kerdel, F.A., Valeyrie-Allanore, L. (eds) Life-Threatening Dermatoses and Emergencies in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79339-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-79339-7_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79338-0
Online ISBN: 978-3-540-79339-7
eBook Packages: MedicineMedicine (R0)